128200-62-4

Downstream Products

• 157553-91-8 2-(trimethylsilyl)ethyl 2,3,6-tri-O-benzyl-4-O-<2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranosyl>-β-D-galactopyranoside 
• 157553-92-9 2-(trimethylsilyl)ethyl 4-O-<3-O-(β-D-galactopyranosyl)-α-D-galactopyranosyl>-β-D-galactopyranoside 

Relevant academic research and scientific papers

METHOD FOR TREATING GALABIOSE-BINDING BACTERIA INFECTIONS

A method for treating infections caused by galabiose-binding bacteria using galabiose derivatives modified at the 3 and anomeric positions. The galabiose-derivatives and compositions of some are also disclosed

Synthesis of the globotetraose tetrasaccharide and terminal tri- and di-saccharide fragments

The 2-(trimethylsilyl)ethyl (TMSEt) β-glycosides of globotetraose 3)-α-D-Gal-(1 -> 4)-β-D-Gal-(1 -> 4)-D-Glc> and the terminal trisaccharide, as well as the methyl α-glycoside 1 of the terminal disaccharide, were synthesised by silver trifluoromethanesulfonate-promoted β-glycosylation of suitably protected galactoside, galabioside, and globotrioside alcohols with 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl chloride, followed by removal of protecting groups.Removal of the anomeric TMSEt group of the globotetraoside and of the terminal trisaccharide, using trifluoroacetic acid-dichloromethane, gave the corresponding hemiacetal sugars 8 and 3.The TMSEt glycoside of the terminal trisaccharide was converted, via the 1-acetate, into the corresponding isobutyl (4) and 3-butylsulfonyl-2-propyl (5) glycosides and into the TMSEt thioglycoside 6 via the glycosyl bromide.